count

(redirected from Reticulocyte count)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.
Related to Reticulocyte count: ferritin, Reticulocyte index

Count

In Common-Law Pleading or Code Pleading, the initial statements made by a plaintiff that set forth a Cause of Action to commence a civil lawsuit; the different points of a plaintiff's declaration, each of which constitute a basis for relief. In Criminal Procedure, one of several parts or charges of an indictment, each accusing the defendant of a different offense.

The term count has been replaced by the word complaint in the Federal Rules of Civil Procedure and many state codes of civil procedure. Sometimes count is used to denote the numbered paragraphs of a complaint, each of which sets out an essential element of the claim.

Federal and state rules of criminal procedure govern the standards that a criminal count must satisfy in federal and state criminal matters.

count

n. each separate statement in a complaint which states a cause of action which, standing alone, would give rise to a lawsuit), or each separate charge in a criminal action. For example, the complaint in a civil (non-criminal) lawsuit might state: First Count (or cause of action) for negligence, and then state the detailed allegations; Second Count for breach of contract, Third Count for debt, and so forth. In a criminal case each count would be a statement of a different alleged crime. There are also so-called common counts which cover various types of debt. (See: common counts)

count

a paragraph in an indictment containing a distinct and separate charge.

COUNT, pleading. This word, derived from the French conte, a narrative, is in our old law books used synonymously with declaration but practice has introduced the following distinction: when the plaintiff's complaint embraces only a single cause of action, and he makes only one statement of it, that statement is called, indifferently, a declaration or count; though the former is the more usual term.
    2. But when the suit embraces two or more causes of action, (each of which of course requires a different statement;) or when the plaintiff makes two or more different statements of one and the same cause of action, each several statement is called a count, and all of them, collectively, constitute the declaration.
    3. In all cases, however, in which there are two or more counts, whether there is actually but one cause of action or several, each count purports, upon the face of it, to disclose a distinct right of action, unconnected with that stated in any of the other counts.
    4. One object proposed, in inserting two or more counts in one declaration, when there is in fact but one cause of action, is, in some cases, to guard against the danger of an insufficient statement of the cause, where a doubt exists as to the legal sufficiency of one or another of two different modes of declaring; but the more usual end proposed in inserting more than one count in such case, is to accommodate the statement to the cause, as far as may be, to the possible state of the proof to be exhibited on trial; or to guard, if possible, against the hazard of the proofs varying materially from the statement of the cause of action; so that if one or more or several counts be not adapted to the evidence, some other of them may be so. Gould on Pl. c. 4, s. 2, 3, 4; Steph. Pl. 279; Doct. Pl. 1 78; 8 Com. Dig. 291; Dane's Ab. Index, h.t.; Bouv. Inst. Index, h.t. In real actions, the declaration is most usually called a count. Steph. Pl. 36, See Common count; Money count.

References in periodicals archive ?
There were no statistically significant differences in the mean hemoglobin level, mean MCV, mean serum TIBC, mean reticulocyte count, and mean ZPP (P > 0.05) between the two groups but the values of serum iron and serum ferritin were significantly higher in transfused patients than that in nontransfused patients (P < 0.0000001).
Absolute reticulocyte count is a calculated index using the values generated from the reticulocyte count percentage and RBC count from the full blood count.
They concluded that in patients with chronic inflammation, an increase in Haemoglobin level of at least 0.81 g/dL at week 6 of iron therapy were best predicted by an increase of Ret-He (Hb content of reticulocytes), transferrin saturation, serum iron level and the reticulocyte count one week after iron therapy.
Haemolysate for haemoglobin estimation, fixed avian red cells for TLC, PBS and reticulocyte count for manual and mechanical testing were prepared in our laboratory.
These markers included reticulocyte count, LDL, and indirect bilirubin.
On the 9th day of hospitalization the laboratory tests showed: Hb 8 gr/dl; WBC 1.5 X [10.sup.9]/l (neutrophils 0.1 X [10.sup.9]/l, lymphocytes 1.2 X [10.sup.9]/l, monocytes 0.2 X [10.sup.9]/l); platelet count 19 X [10.sup.9]/l (normal-sized platelets in peripheral blood smear); corrected reticulocyte index 0.6% (absolute reticulocyte count 4 X [10.sup.9]/l).
Evaluation of anemia should consist of at least the following measurements: Hgb, Hct, red blood cell count, reticulocyte count, iron parameters (i.e., serum iron, total iron binding capacity [TIBC], percent transferrin saturation [TSAT; serum iron x 100 divided by TIBC], serum ferritin), and a test for occult blood in the stool.
The presentation titled "A Phase 2 Open-label Proof-of-concept Study of the Oral, Small Molecule Factor D Inhibitor, ACH-4471, in Untreated Patients with Paroxysmal Nocturnal Hemoglobinuria" presents data showing: Reduction in lactate dehydrogenase at Day 28 compared to baseline; Improvement in additional markers of PNH, including hemoglobin, reticulocyte count, bilirubin, clone size, and Functional Assessment of Chronic Illness Therapy Fatigue scores compared to baseline at Days 28 and 84; As previously described in December, one patient discontinued therapy for an SAE however the drug was generally well tolerated with 8 of 10 patients electing to continue into a long-term extension study with durability of effect and long-term tolerability up to 2 years.
Follow-up evaluation was done with CBC, RBC indices, and reticulocyte count.
She was diagnosed with as autoimmune hemolytic anemia (ATHA) based on a high reticulocyte count, positive direct Coombs test, hemoglobinuria, and low haptoglobin level, and received the conventional treatment of prednisone (2 mg/kg in divided doses) and blood transfusions.
An automated CBC and WBC differential count analysis was performed on all 2114 samples; an automated reticulocyte count was performed on 58 samples upon clinician request.